Several Blood Pressure Drugs Linked to Increased Risk of Cancer
Researchers at Case Western University School of Medicine have concluded that several widely used blood pressure drugs may lead to cancer in some patients. In a meta-analysis of nine published studies, Dr. Ilke Sipahi and his colleagues at Case Western found that blood pressure drugs called angiotensin-receptor blockers (ARBs) may increase the risk of a new cancer by 8 percent. The drugs in question include Diovan, Micardis, Blopress, Atacand, Amias and Cozaar.
However, the study did not find an increased risk of dying of cancer; some say this is because the follow-up phase in the trials was too short. Many experts are calling the findings “disturbing” and “provocative,” while others claim that the study is not scientific evidence but rather a “signal” calling for regulators to take a closer look. Dr. Sipahi and his colleagues agree that their findings are only a “first cut” at the issue but point out that “tens of millions of patients” who use the drugs in question could be at risk.
The study comes just two days after the U.S. Food and Drug Administration (FDA) announced it was evaluating data from two clinical trials in which patients taking the blood pressure drug Benicar (also an ARB) had a higher risk of cardiovascular-induced death.
Some are calling the study flawed and unpersuasive. According to some experts, the study failed to show scientific evidence and that even after a thorough analysis of the nine studies, the most one could blame the drug for is revealing an existing cancer. Researchers fear that the findings will prompt some patients to stop using the drugs and place themselves in grave danger. Meanwhile, physicians are being urged to prescribe the drugs in question conservatively or administer an alternative treatment when possible.
Blood Pressure Drug Lawsuits
While the latest findings of the increased risk of cancer as a result of ARBs may not be enough to prove a defective drug case at this time, the highly experienced Pensacola personal injury lawyers of Aylstock, Witkin, Kreis and Overholtz, PLLC, are closely monitoring the latest information and are ready to represent any victims who may have developed cancer as a result of an ARB drug.
The Pensacola personal injury attorneys of Aylstock, Witkin Kreis & Overholtz handle national litigation across the United States for victims injured by defective pharmaceuticals and medical devices. They have successfully represented and obtained substantial compensation for a number of patients who have been harmed by defective drugs. To learn more about filing a personal injury lawsuit against a drug manufacturer, please contact AWKO law today at (844) 794-7402.